Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ovarian Neoplasms

  Free Subscription

15.01.2024

1 BMC Cancer
1 Br J Cancer
1 Curr Treat Options Oncol
2 Gynecol Oncol
1 Hum Pathol
1 Int J Oncol
1 J Clin Oncol



    BMC Cancer

  1. WEIGELT J, Petrosyan M, Oliveira-Ferrer L, Schmalfeldt B, et al
    Ovarian cancer cells regulate their mitochondrial content and high mitochondrial content is associated with a poor prognosis.
    BMC Cancer. 2024;24:43.
    >> Share


    Br J Cancer

  2. YOUNG HAN C, Bedia JS, Yang WL, Hawley SJ, et al
    Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer.
    Br J Cancer. 2024 Jan 9. doi: 10.1038/s41416-023-02560.
    >> Share


    Curr Treat Options Oncol

  3. ISMAIL A, Choi S, Boussios S
    Frontiers of Ovarian Carcinosarcoma.
    Curr Treat Options Oncol. 2023;24:1667-1682.
    >> Share


    Gynecol Oncol

  4. GRESSEL GM, Frey MK, Norquist B, Senter L, et al
    Germline and somatic testing for ovarian Cancer: An SGO clinical practice statement.
    Gynecol Oncol. 2024;181:170-178.
    >> Share

  5. SZAMRETA EA, Monberg MJ, Desai KD, Li Y, et al
    Prognosis and conditional survival among women with newly diagnosed ovarian cancer.
    Gynecol Oncol. 2024;180:170-177.
    >> Share


    Hum Pathol

  6. QIJUN C, Wei W, Cheng W, Dongni L, et al
    Clinicopathological features and molecular genetic changes in 17 cases of uterine tumor resembling ovarian sex cord tumor.
    Hum Pathol. 2023 Nov 22:S0046-8177(23)00229.
    >> Share


    Int J Oncol

  7. GRUNT TW, Wagner R, Ries A, Berghoff AS, et al
    Targeting endogenous fatty acid synthesis stimulates the migration of ovarian cancer cells to adipocytes and promotes the transport of fatty acids from adipocytes to cancer cells.
    Int J Oncol. 2024;64:24.
    >> Share


    J Clin Oncol

  8. TJOKROWIDJAJA A, Friedlander ML, Ledermann JA, Coleman RL, et al
    Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase Inhibitor.
    J Clin Oncol. 2024 Jan 12:JCO2301182. doi: 10.1200/JCO.23.01182.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016